[Federal Register Volume 61, Number 96 (Thursday, May 16, 1996)]
[Notices]
[Pages 24798-24799]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-12263]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    Michael W. Washabaugh, Ph.D., Johns Hopkins University: Based on an 
investigation conducted by the institution as well as information 
obtained by ORI during its oversight review, ORI found that Michael W. 
Washabaugh, Ph.D., Associate Professor of Biochemistry, Department of 
Biochemistry, Johns Hopkins University School of Hygiene and Public 
Health, committed scientific misconduct by reporting falsified and/or 
fabricated research data in two grant applications submitted to the 
National Institutes of Health.
    Specifically, Dr. Washabaugh (1) reported falsified results of 
experiments concerning the number of DTNB (5,5'-dithiobis [2-
nitrobenzoate]) reactive thiols in native thiamin binding protein in a 
grant application entitled ``Mechanism of a periplasmic permease,'' and 
(2) reported falsified and/or fabricated portions of data presented in 
two separate figures to support his hypothesis of thiamin binding to 
thiamin binding protein in grant applications entitled ``Mechanism of a 
periplasmic permease'' and ``Mechanisms of enzymic and non-enzymic 
thiamin reactions.''
    Dr. Washabaugh has entered into a Voluntary Exclusion Agreement 
with ORI in which he has voluntarily agreed, for the four (4) year 
period beginning May 7, 1996, to exclude himself from:
    (1) Any contracting or subcontracting with any agency of the United 
States Government and from eligibility for, or involvement in, 
nonprocurement transactions (e.g., grants and cooperative agreements) 
of the United States Government as defined in 45 C.F.R. Part 76 
(Debarment Regulations), and
    (2) Serving in any advisory capacity to the Public Health Service 
(PHS), including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.

[[Page 24799]]

    No scientific publications were required to be corrected as part of 
this Agreement.

FOR FURTHER INFORMATION CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 5515 Security Lane, Suite 
700, Rockville, MD 20852.
Chris B. Pascal, J.D.,
Acting Director, Office of Research Integrity.
[FR Doc. 96-12263 Filed 5-15-96; 8:45 am]
BILLING CODE 4160-17-P